 | LAVA Therapeutics N.V. | |||
| NMS : LVTX || Location: Netherlands | ||||
$2.98+0.13 (+4.56%) |
0.11 M | 2.98 - 2.98 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.212 M |
| March 15, 2024 | 0.322 M |
| Feb. 29, 2024 | 0.056 M |
| Feb. 15, 2024 | 0.010 M |
| Jan. 31, 2024 | 0.088 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.13 | -0.24 | -88.24% |
| 09/30/2023 | -0.50 | -0.34 | 31.97% |
| 06/30/2023 | -0.48 | -0.48 | 0.58% |
| 03/31/2023 | -0.53 | -0.53 | 0.08% |
| 12/31/2022 | -0.65 | -0.57 | 11.83% |
LVTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 26.289M | Shares Float | 12.072M |
| Short Float | 0.212M | Market Cap | 78.34M |
| Institution ownership | 33.16% | Insider ownership | 28.722% |
| Earnings Date | 05/15/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.57 | Forward EPS | -2.19 |